TwoStep Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- TwoStep Therapeutics's estimated annual revenue is currently $930k per year.
- TwoStep Therapeutics's estimated revenue per employee is $155,000
Employee Data
- TwoStep Therapeutics has 6 Employees.
- TwoStep Therapeutics grew their employee count by 50% last year.
TwoStep Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | Associate Director | Reveal Email/Phone |
3 | Associate Director | Reveal Email/Phone |
4 | Scientist II | Reveal Email/Phone |
TwoStep Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is TwoStep Therapeutics?
TwoStep Therapeutics is pioneering a multi-targeting platform to advance a pipeline of targeted therapies that are broadly applicable across solid tumors. With this approach, the company aims to transform cancer treatment by extending precision medicines to more diverse tumor types and patient populations, for which few options exist. TwoStep Therapeutics was co-founded by CEO, Caitlyn Miller, in collaboration with world-renowned academic entrepreneurs at Stanford University: Jennifer Cochran, Ronald Levy, and Nobel Laureate Carolyn Bertozzi. For more information, visit www.twosteptx.com.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 6 | -33% | $12M |
#2 | $0.9M | 6 | 0% | N/A |
#3 | $0.1M | 6 | 0% | $50M |
#4 | $0.9M | 6 | -45% | N/A |
#5 | $0.5M | 6 | -60% | N/A |